Metabolix Names Heike Sederoff, Ph.D. to Yield10 Bioscience Scientific Advisory Board
September 27 2016 - 9:00AM
Metabolix, Inc. (NASDAQ:MBLX), today announced that Heike Sederoff,
Ph.D. Professor, Department of Plant and Microbial Biology at North
Carolina State University (“NC State”) has been named to the
Yield10 Bioscience Scientific Advisory Board (“SAB”). Yield10
Bioscience, the crop science venture launched by Metabolix in 2015,
is focused on developing proprietary, breakthrough technologies to
create step-changes in yield for major food and feed crops to
enhance global food security.
“We are pleased to welcome Dr. Sederoff to our Scientific
Advisory Board,” said Oliver Peoples, Ph.D., chief scientific
officer. “We have collaborated with Dr. Sederoff and her team at NC
State on advanced metabolic engineering technologies for improving
crop yield using camelina as a model system. We look forward to
Heike’s contributions in her role as an advisor to our team as we
work in 2016 to translate our approach to boosting crop yield and
drought resistance to agriculturally significant crops and move
from greenhouse to field trials.”
“We have collaborated with the Yield10 team on grants supporting
advanced research to improve seed and biomass yield in oilseed
crops,” said Heike Sederoff, Ph.D. Professor, Department of Plant
and Microbial Biology at North Carolina State University. “Our work
focused on yield improvement using camelina has produced
encouraging results and we look forward to continue working with
the Yield10 team to engineer new plant yield traits applicable to
important feed and food crops.”
Heike Sederoff, Ph.D. is currently Professor in the Department
of Plant and Molecular Biology and Systems and Synthetic Biology
Chair at North Carolina State University. Dr. Sederoff’s recent
research has focused on the study of plant systems and synthetic
biology. She has used metabolic engineering methods to increase
carbon assimilation and allocation in an oilseed crop and in model
plant species including marine algae. Dr. Sederoff received an M.S.
in Biochemistry and a Ph.D. in Plant Biochemistry at University of
Göttingen, Germany.
Earlier in 2016, Yield10 Bioscience named Michael Lassner,
Ph.D., former vice president of trait discovery at Dupont Pioneer
and Danny Schnell, Ph.D., Professor and Chair of the Department of
Plant Biology at Michigan State University, to its
SAB.
About Metabolix
Metabolix, Inc. is implementing a strategic plan under which the
Company has wound down its legacy PHA biopolymer business and
Yield10 Bioscience will become its core business with a focus on
developing disruptive technologies for step-change improvements in
crop yield. Yield10 is leveraging Metabolix’s extensive track
record of innovation based around optimizing the flow of carbon
intermediates in living systems. Yield10 is working on new
approaches to improve fundamental elements of plant metabolism
through enhanced photosynthetic efficiency and directed carbon
utilization. Yield10 is advancing several yield traits in
development in crops such as camelina, canola, soybean and corn.
The Company is based in Woburn, MA.
For more information, visit www.metabolix.com. (MBLX-G)
For more information on Yield10 Bioscience, visit Yield10.
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical statements, including,
without limitation, expectations regarding the progress of Yield10,
constitute forward-looking statements. Such forward-looking
statements are subject to a number of risks and uncertainties that
could cause actual results to differ materially from those
anticipated, including the risks and uncertainties detailed in
Metabolix's filings with the Securities and Exchange Commission.
Metabolix assumes no obligation to update any forward-looking
information contained in this press release or with respect to the
announcements described herein.
Metabolix Contact:
Lynne H. Brum, 617-682-4693, LBrum@metabolix.com
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Sep 2023 to Sep 2024